25 results found
Location: Education > Courses > Community Gynaecology > Community Gynaecology Course Modules Course Content Find module content, dates and individual module application information below. Module 1 Contraception Topics to include the following: Hormonal contraception Long Acting Reversible Contraception (LARC) Emergency contraception Termination of pregnancy for the 5k · 3 October 2023 · Members Only
Location: Education > Women's Health Programme > Useful Links The following links have been compiled by the directors of the Women's Health Programme. Contraception WHO Medical Eligibility Criteria for Contraceptive Use NICE Guideline on Long Acting Reversible Contraceptives (LARC) International Planned Parenthood Federation, Directory 4k · 28 September 2023 · Members Only
Location: ICGP Website
ICGP journal supplement
Library Catalogue
· 51 pages
·
ICGP
Location: Education > Women's Health Programme > Menopause Menopause Theory Course ICGP is delighted to offer updated menopause education primarily aimed at GPs and GP Trainees, and also open to nurses and other healthcare professionals. The updated curriculum will address the latest evidence base to ensure that patient care for menopause consultations is 2k · 28 March 2023 · Members Only
Location: ICGP Website
ICGP AGM 2019 PowerPoint Presentation
Library Catalogue
· 41 pages
·
Lundy, Deirdre Dr.
Location: ICGP Website
ICGP AGM 2018 PowerPoint Presentation
Library Catalogue
· 68 pages
·
Lundy, Deirdre Dr.
Location: ICGP Website
ICGP Winter Meeting
2016 PowerPoint Presentation
Library Catalogue
· 64 pages
·
Lundy, Deirdre Dr
Location: ICGP Website
ICGP Summer School 2015 PowerPoint Presentation
Library Catalogue
· 69 pages
·
Lundy, Deirdre Dr.
Location: ICGP Website
The Quality in Practice Programme of the Irish College of General Practitioners supported by Glaxo Wellcome through The ICGP Research & Education Foundation.
Library Catalogue
· 54 pages
·
Favier, Mary Dr and Boland, Michael Dr · ICGP
Location: Library & Publications > Public Health The European Medicines Agency's safety committee (PRAC) has concluded a review of Xeljanz (tofacitinib) and recommended updates to product information and new risk minimisation measures. 5k · 4 November 2019 · Members Only